OTC Picks

[StockDetective]

$ARYC The College of American Pathologists CAP:

Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists

Sunnyvale, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen Proficiency Testing (PT) with the College of American Pathologists (CAP). The SC-2017, SA-2018 and SB-2018 triannual CAP Diagnostic Immunology Surveys require highly quantitative measurements of immunoglobulin E (IgE), the antibody molecules measured by the company’s finger stick allergy microarray tests. Arrayit’s highly accurate PT performance showcases the robustness of the company’s proprietary allergy testing platform and reagents, which are increasingly being leveraged by doctors as a tool to diagnose and treat allergy and asthma.

http://www.globenewswire.com/news-release/2018/10/08/1617820/0/en/Arrayit-Corporation-Aces-Three-Consecutive-Rounds-of-Proficiency-Testing-with-the-College-of-American-Pathologists.html



Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP). Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human bloodstream indicative of allergy and asthma. The CAP SA2018 Diagnostic Immunology Survey proficiency test included 1,677 clinical laboratories utilizing IgE testing equipment manufactured by major corporations in the life sciences, molecular diagnostics and pharmaceutical markets. CAP, the international proficiency testing leader, ensures and improves healthcare quality by fostering clinical excellence through the impartial and carefully-supervised proficiency testing process.

Arrayit uses its patented and proprietary microarray technology to accurately and rapidly test IgE levels in patient blood card specimens shipped to its Silicon Valley clinical laboratory by hospitals, health maintenance organizations (HMOs), clinical laboratories, insured patients in physician groups, and consumers through the assistance of a medical doctor. Arrayit leverages miniaturization, allergen and sample multiplexing, and a high degree of robotic and software automation to deliver test results quickly and non-invasively using finger stick blood sampling.

http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Scores_100/arrayit_corporation_scores_100-_on_proficiency_testing_conducted.html



From 8/26/2018: Arrayit CLIA clinical team completes SB2018 proficiency testing for the College of American Pathologists CAP as required for ongoing certification with the California Department of Public Health CPDH and the Centers for Medicare and Medicaid Services CMS http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html

Arrayit CLIA clinical team completes SB2018 proficiency testing for the College of American Pathologists CAP as required for ongoing certification with the California Department of Public Health CPDH and the Centers for Medicare and Medicaid Services CMS https://t.co/1POQ5sm3CJ pic.twitter.com/T3FQqNnG9u

— Arrayit Corporation (@arrayit) August 26, 2018

https://m.facebook.com/Arrayit/photos/a.10150154876072259/10156314713337259/?type=3
Report TOS